MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION

Clinical trials for MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION explained in plain language.

Never miss a new study

Get alerted when new MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION trials appear

Sign up with your email to follow new studies for MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Eye injection study aims for fewer shots to save sight

Disease control Completed

This study tested if a higher dose of an existing eye injection (aflibercept 8 mg) could be given less often to control vision loss from macular edema, a swelling caused by a blocked retinal vein. Nearly 900 participants received either the higher dose or the standard lower dose,…

Matched conditions: MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION

Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control

Last updated Apr 02, 2026 03:56 UTC

MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION

Get alerted when new MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION trials appear

Eye injection study aims for fewer shots to save sight